A large, multi-institutional clinical trial conducted by emergency medicine experts from Stellenbosch University (SU), in partnership with United States Department of Defence, will evaluate the use of synthetic blood products for the resuscitation of trauma victims before arrival at hospital.
The Division of Emergency Medicine at SU’s Faculty of Medicine and Health Sciences will be the coordinating centre for the study, which includes 21 hospitals and 27 ambulance bases across South Africa. These include public and private academic institutions and healthcare facilities. For this study, SU is also partnering with the Universities of Cape Town (UCT), KwaZulu-Natal (UKZN), Witwatersrand (Wits) and Pretoria (UP), collectively representing the body of academic emergency medicine in South Africa.
The study will evaluate the use of the haemoglobin-based oxygen carrier Hemopure (HbO2 Therapeutics LLC) together with Bioplasma FDP (National Biologics Institute), a freez